Background : Evidence for an effect of zinc supplementation on growth in every young infants in developing countries is scarce and inconsistent.
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After randomization and pair matched neonates were grouped into two groups, 100 neonates were included in group A and 100 neonates in group B.
In the first 28 days of life, the A group received Syrup D 1 2.5ml /day in and B group received syrup D 2 2.5ml /day.
The syrup administered to the study neonate in two groups were prepared by Orion Laboratories Ltd. drug manufacturing company. Syrup D 1 2.5ml contains zinc 5mg was given to A group and Placebo (D 2 ) for B group. The two syrups were indistinguishable in taste and color and code of syrup 'D 1 ' and 'D 2 ' was kept strictly confidential with the pharmacist.
The parents or care giver were instructed to feed syrup D 1 2.5ml or syrup D 2 every morning at 10 am to their neonate up to 28 days.
Measurement of weight of case and control without cloth before feeding at 9a.m after 3 days, 7 days, 14 days, 21 days and 28 days and recorded in a record form. The overall supervision was maintained by researcher. At the end of the study the code of syrup was decoded and found 'D 2 ' for Placebo and D 1 for zinc. Data were analyzed by using statistical software SPSS.
Result : Among the study subjects 54% of them were male and 46% were female, of them 78% were preterm, and were 22% IUGR. The mean (±SD) birth weight was 1789.50 ± 228.89gm is for cases and controls. Three days after birth, weight decreases to (1610.50 ± 255.38gms) in cases and to (1613.00 ± 215.04 gms) in controls. More weight gain in cases than controls was observed after 7 days of birth. Highly significant weight gain after 21 days (2261.50 ± 296.14 gms) in cases than controls (2165.50 ± 243.47 gms) and 28 days (2665.00 ± 331.52 gms) in cases observed than controls (2374.00 ± 410.07 gms). So mean weight after 21 st and 28 th days of cases was significantly higher (P<0.05) than that of control group respectively.
Mean weight gain (31.37 ± 6.91 gm/day) of cases was significantly higher (P<0.000) than the mean weight gain (21.63 ± 5.67 gm/day) of control group. Mean weight of final follow up of zinc group was 2665.00 ± 331.52 and placebo group was 2374.00 ± 4107. (P<0.000) when compared with mean birth weight.
Linear curve of effectiveness of the program on weight for age z-score by follow up days. It was found that increment of effectiveness in Zinc group was higher than that of placebo group. Eighty four percent of cases gained weight more than control group. Problems like physiological Jaundice, infection, convulsion, were less in zinc group compared to control group.
Introduction
Zinc is essential for growth. Zinc supplementation accelerated weight gain by increases circulating insulin like growth factor (IGF-I) 1-3 , appetite 4, 5, 6, 7 , improved ingestion of energy and protein 8, 9, 10 . IGF-I is the mediator of the growth promoting action of growth hormone. Positive effect of zinc supplementation circulating IGF-1 was reported by Payne 10 , Nakamura 11 . Zinc may promote growth through changes in protein synthesis and cell replication, contributing to accumulation of lean tissue 11, 12 . Zinc plays a role in nucleic acid metabolism, in many biochemical functions, hormone structure and in genetic transcription factors 13, 14 .
Zinc, which has an important immunology and growth promoting role is among micronutrients. Zinc supplementation significantly reduces the incidence of low birth weight 15 . Low birth weight babies born to our rural mother contributes to high infant deaths. So in order find out an easy and low method for effective treat of LBW the present study designed and conducted.
Materials and Methods
This study was carried out at the Neonatal ward of Sher-EBangla Medical College Hospital, Barisal, Bangladesh. The duration of study was from May 2005 to February 2007. One hundred pairs of Low birth weight neonates were included in this study.
The selection criteria were:
a. Birth weight less than 2.5kg (between 1200 gm to 2300 gm) with gestation period between 28 and 42 weeks.
b Neonates who where admitted in the first day of life and the mother of whom consented to reside in the hospital for continues 28 days.
c. Neonates of mother who did not have history of zinc supplementation during pregnancy.
The exclusion criteria-a.Neonates admitted with respiratory distress syndrome (RDS), Birth Asphyxia, Hypothermia etc. b. The parents did not consent to participate in the study.
In order to obtain quality data, a standard Questionnaire was developed for this study, which included newborn health information; measurement of weights of neonates, gestational age, and any LBW related problems. The questionnaire was pre-tested and finalized before date collection.
Study Procedure :
After admission a detailed history and thorough clinical examination was done in all cases and controls. Gestational age was assessed according to new Ballared scoring system. Then parents were informed and consent was taken from them after explaining the purpose of the study. Close monitoring was done for study neonates.
The case selection method: 1 Each of the enrolled neonates consecutively by following inclusion and exclusion criteria and was randomized either of the two groups. 2 The case and control were matched by weight, sex, type of LBW and type of feeding.
One hundred pairs, representing 200 neonates were included in the study. After randomization and pair matched neonates were grouped into two groups, 100 neonates were included group A, and 100 neonates in group B.
Zinc Supplement and placebo
The syrups administered for the neonates of both groups were prepared by Orion Laboratories Ltd., Dhaka-1208. Syrup for the case neonates was prepared by elemental zinc, sucrose, flavor and preservatives as 100 ml in a sealed bottle with beautiful carton of which 2.5 ml contained 5 mg of zinc. The placebo syrup with same color and taste contained sucrose, flavor and preservatives but no zinc. The syrups were labeled as D 1 & D 2 and these codes were kept confidential with the pharmacist. Neither the investigator nor the subjects knew the intervention agent. It was found that increment of effectiveness in Zinc group was higher than that of placebo group. Eighty four percent of cases gained weight more than control group. Problems like physiological Jaundice, infection, convulsion, were less in zinc group compared to control group. Table-III showed that mean weight of IUGR group of cases was higher than the mean weight of preterm group across the follow up days. Similarly trend was found in control group.
Discussion
The zinc supplemented group gained 84% weight than control. zinc supplementation accelerated weight gain. Most zinc supplementation trials performed in the United States and Canada on short but well-nourished children did not report a stimulatory effect on weight gain 16, 17, 18 . Our findings, however, agree with those trials performed in malnourished populations in developing countries where zinc supplementation increased gains in weight and height 5, 18, 19 . The weight response of our subjects to zinc supplementation may be explained by their low initial WAZ score. Our study shows a growth response to zinc supplementation in neonates of both sexes, which agrees with the findings of other zinc supplementation studies of malnourished children in developing countries, where zinc deficiency is likely to be severe. However, in children with mild zinc deficiency, increases in growth have usually been greater in boys than in girls, perhaps because of their greater requirement for zinc 14 Table 3 showed that mean wt of Exclusive Breast feeding by suckling of cases were higher than the mean weight of 10% dextrose + Express breast milk by NG tube + breast feeding and Formula feeding + Express breast milk + Breast feeding across the follow up days respectively. Similarly trend was found in control group.
33 responsible for the growth-promoting effect of zinc. The stimulatory effect of zinc on growth velocity was still significant after the incidence of infections was controlled for. Further more, Schlesinger et al 196 reported a growth-stimulating effect of zinc without significant changes in the incidence of infections.
Because IGF-I is the mediator of the growth-promoting action of growth hormone, low circulating IGF-I observed in proteinenergy malnutrition is believed to be responsible for the growth retardation observed in this condition. Experimental zinc deficiency is also associated with low IGF-I in humans and animals 19-32, and there is evidence that zinc per se may regulate circulating IGF-I concentrations. These observations suggest that zinc deficiency may impair growth by altering circulating IGF-I. Although a positive effect of zinc supplementation on circulating IGF-I was reported previously 10 In this study mean weight gain (31.37±6.91) (p<0.00) in zinc group than the mean weight gain (21.63±5.67 gm/day) of control group. It is highly likely that zinc supplements need to be given every day along with appropriate balance diet because there may be no adequate stores of zinc and other nutrients and zinc turnover is also rapid.
The accelerated weight gain in LBW neonates, showed 900 grams in cases and 600gms in controls. Average daily weight gains in cases 32 gms and in controls 21 gms. A study conducted by Sharivastava et al on malnourished children aged 8 to 24 months showed that children supplemented with zinc for 3 months had a significant weight gain (p<001).Findings of this study agree with those of trials performed in malnourished populations in developing countries where zinc supplementation increased gains in weight. Our suggests that zinc supplementation stimulated growth. The effect of zinc may result from increase appetite and improved ingestion of energy and protein. Zinc may promote growth through changes in protein synthesis and cell replication, contributing to accumulation of lean tissue.
Jaundice is a common problem in low birth weight Neonates. In this study, 15% of cases and 24% of controls of low birth weight neonates developed Jaundice. Neonatal infection was more (26%) in controls but less in cases (7%). In this study convulsion was 2% in cases and 3% in controls, and Apnea was 4% in cases and 3% in controls.
